Sanofi Might Pull Down Shutters For Two Vaccine Plants In India
Sanofi pulls out of Hanmi diabetes drug trials, ends contract
Lexicon slumps after Sanofi pulls out of deal
Sanofi raises profit forecast following positive Q2 results - PMLiVE
Sanofi pulls Lyxumia's US filing - PMLiVE
Sanofi pulls out of Zika vaccine collaboration as feds gut its R&D contract | Fierce Pharma
Sanofi Trial Failure Halts Work on Breast Cancer Treatment Amcenestrant
Sanofi abandoning Auvi-Q after dosage problems led to total recall
Reaction 'excessive' to Sanofi's upcoming litigation: analysts
Dupixent sales of €10B? We're on track, Sanofi CEO Hudson says | Fierce Pharma
Sanofi pulls out of mRNA COVID vaccine development - TeleTrader.com
Stocks To Watch: Sanofi Sees Relative Strength Rating Jump To 83 | Investor's Business Daily
Sanofi to pull the plug on mRNA Covid-19 vaccine after rivals' success
Sanofi pulls out of Revolution Medicines deal on SHP2 inhibitor RMC-46
Zantac Recall Widens as Sanofi Pulls Its Drug Over Carcinogen Fears - The New York Times
Sanofi pulls Zantac from U.S. and Canada after carcinogen found | Euronews
Sanofi pulls out patent plea for TB drug in EU, but not in India - Times of India
Sanofi pulls IGM into dealmaking whirlwind, paying $150M upfront to form 6-target R&D pact | Fierce Biotech
